Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29%

Commodore Capital reported a sale of 850,000 shares of Nuvalent (NASDAQ:NUVL) in its latest SEC filing dated February 17, 2026, with the estimated transaction value at $83.81 million based on quarterly average pricing. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Commodore Capital sold 850,000 shares of Nuvalent during the fourth quarter of 2025. The estimated value of these sales was $83.81 million based on the average closing price for the period ...